2021 Breakthrough Wearable Tech: Overview on Hapbee (HAPB, HAPBF) and its Vision
LIVE CHART
https://youtu.be/X_DRzL6MAOU
Interview: Scott Donnell from Hapbee (HAPB, HAPBF) on Wall Street Reporter.
Transcript follows.
Hapbee CEO Live with the Wall Street Reporter
Listen in as Hapbee CEO Scott Donnell chats with the Wall Street Reporter about all things...
Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.
The 2021 Biotech Six Pack: Stocks We Expect to Double!
These are ideas #3 and #4 for the 'Biotech Six Pack' list. The first addition...
Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise $166 Million.
Hepion (HEPA) Banked $88 Million Yesterday, Citius (CTXR) Banks $78 Million Today.
We're beginning to believe (and it may be a "brief-belief") that during...
Bill Gates Warns That a Next Pandemic Could Be 10 Times Worse.
Well Alrighty Then. Just as we Were Starting to Get Comfortable Sitting on a Barstool Again..
The Microsoft co-founder explained that humanity is not prepared...
Mitesco (MITI) $0.45 to Open its First Medical Clinic.
LIVE QUOTE
By George, they did it.
Many companies public or private fall short of their ambitious plans. They either kick the can, modify plans...
Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.
The 2021 Biotech Six Pack, Six Stocks We Expect to Double.
We're still putting the 2021 list together now, but rather than waiting to announce...
Short Squeeze Mania.
Citius Pharma (CTXR) Locked and Loaded.
Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen From Citius Pharma (CTXR) Since We've...
Make Hay While the Sun Shines. Up 6,400%.
Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have Another Double. BioSig...
And it’s Official. We Have Another Double. BioSig (BSGM) up 103% in Four Months.
This is crazy. Wish we were 'traders' but sadly we are not. This is the most fun we've had since 1998, pre-dotcom boom. And...














